Drug intelligence / Profile preview

donepezil + woohwangchungsimwon

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

This is a combination therapy consisting of donepezil, an acetylcholinesterase inhibitor, and Woohwangchungsimwon, a traditional herbal medicine. Donepezil works by selectively and reversibly inhibiting the acetylcholinesterase enzyme in the central nervous system, thereby increasing acetylcholine levels and improving cognitive and behavioral symptoms associated with Alzheimer's disease. Woohwangchungsimwon is frequently prescribed for neuropsychiatric disorders in traditional Korean medicine and has been reported to have beneficial effects on behavioral and psychological symptoms of dementia. The combination is being studied for its potential to alleviate these symptoms in patients with probable Alzheimer's disease[1][2][4]. A randomized controlled trial is underway to evaluate efficacy and safety over 24 weeks, focusing on outcomes such as neuropsychiatric inventory scores, cognitive function, dementia severity, quality of life, depression, anxiety, insomnia, adverse reactions, vital signs monitoring, and laboratory tests[1][2].

Other names
donepezil + woohwangchungsimwon
02

Targets

Acetylcholinesterase

Beyond the preview

Go deeper on donepezil + woohwangchungsimwon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on donepezil + woohwangchungsimwon.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call